Arena Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Gross
Arena Pharmaceuticals, Inc. had Finite-Lived Intangible Assets, Gross of $2.36 million as of 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2017-03-15
- 2016-12-31: Finite-Lived Intangible Assets, Gross $2.36M.
- 2015-12-31: Finite-Lived Intangible Assets, Gross $12.96M.
- 2014-12-31: Finite-Lived Intangible Assets, Gross $13.05M.
- 2013-12-31: Finite-Lived Intangible Assets, Gross $14.54M.
| Period end | Finite-Lived Intangible Assets, Gross | Finite-Lived Intangible Assets, Gross as first filed |
|---|---|---|
| 2016-12-31 | $2.36M 10-K · filed 2017-03-15 | |
| 2015-12-31 | $12.96M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $13.05M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $14.54M 10-K · filed 2015-03-02 | |
| 2012-12-31 | $14.15M 10-K · filed 2014-03-03 | $31.36M 10-K · filed 2013-03-01 |
| 2011-12-31 | $30.95M 10-K · filed 2013-03-01 |